SGHT: Sight Sciences, Inc. Forvard P/E multiplikatori

sightsciences.com (SGHT) grafik logotipi

GURU.Markets platformasidagi aktiv qiymati grafigida aks etgan forward P/E dinamikasi 0.00 darajasida turibdi. Sight Sciences, Inc. (SGHT) kompaniyasining o'sishi glaukomani davolashning innovatsion usullariga bo'lgan talab, sug'urta to'lovlarining mavjudligi va jarrohlar malakasini oshirish bilan bog'liq. Oftalmologiya sektori savdo mojarolari va siyosiy sanksiyalardan xoli bo'lib qolganligi sababli, biznes global sotuvlarga tayanadi.

sightsciences.com - SGHT Narxning kutilayotgan foydaga nisbati (davr: 04.07.2022 - 16.11.2026)

Sight Sciences (SGHT) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Fundamental baholash:SGHT Sight Sciences Inc
sightsciences.com brendining mahsuloti

Forward P/E ko'rsatkichi kutilayotgan sof foydaga asoslangan holda investitsiyalarning qoplanish muddatini belgilaydi. Ushbu metrika kelajakdagi daromadning har bir birligi narxini o'lchab, aktivning haddan tashqari qimmat yoki arzon baholanganligini aniqlaydi. Sight Sciences, Inc. (SGHT) uchun ushbu hisob-kitob klinikalarda oftalmologik uskunalarning joriy etilish darajasiga bevosita bog'liq. Sight Sciences, Inc. (SGHT) uchun forward P/E koeffitsiyenti dinamikasi glaukomani davolash tizimlarining tijoratlashtirilishiga bo'lgan bozor ishonchini aks ettiradi. Ushbu grafikdagi barqaror tendentsiya kapitalning chidamliligini tasdiqlaydi.

Sight Sciences, Inc. raqobatchilari

Forvard P/E multiplikatori BSX|EW: Narxning kutilayotgan foydaga nisbati|ResMed Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Insulet (PODD)|zimmerbiomet.com - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CooperCompanies|ALGN: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati ATEC (Alphatec)|Prognoz qilingan narxning foydaga nisbati AORT (Artivion)|ENOV (Enovis Corp) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Integra LifeSciences Inc. IART|ESTA - Prognoz qilingan narxning foydaga nisbati|Beta Bionics, Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati IRADIMED CORPORATION|EMBC: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati TNDM|AXGN (Axogen Surgical) - Forvard P/E multiplikatori|SI-BONE Corp (SIBN) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori OFIX|Forvard P/E multiplikatori bioventus.com (BVS)|Forvard P/E multiplikatori KIDS (OrthoPediatrics Corp)|Forvard P/E multiplikatori Treace Medical Concepts Inc TMCI|SRTA - Kelajakdagi narxning foydaga nisbati|CARL: Kelajakdagi narxning foydaga nisbati|RXST (RxSight, Inc.) - Prognoz qilingan narxning foydaga nisbati|ClearPoint Neuro Inc. - Kelajakdagi narx-foyda multiplikatori|STXS (Stereotaxis Corporation) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Neuronetics Inc. STIM|Kelajakdagi narxning foydaga nisbati orchestrabiomed.com (OBIO)|Anika (ANIK) - Forvard narx-foyda multiplikatori|InspireMD Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Jin Medical International Ltd ZJYL|Vivani Medical Inc - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati MODD (Modular Med)|MYO (Myomo Inc.) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Envoy Medical, Inc. (COCH)|Forvard P/E multiplikatori VVOS|NVNO - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati sintx.com SINT|TNON: Narxning kelajakdagi foydaga nisbati|LFWD: Prognoz qilingan narxning foydaga nisbati|autonomix.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|INVO Bioscience, Inc. (IVF) - Kelajakdagi narxning foydaga nisbati|BBLG (Bone Biologics Corp.) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati AXNX|Biolase Inc. (BIOL) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Dynatronics Corp. (DYNT)|Forvard P/E multiplikatori Paragon 28 (FNA)|Kelajakdagi narxning foydaga nisbati INVO Bioscience INVO